Key Quantitative Figures

Financial Performance (Year Ended March 31, 2026):

  • Total Revenue: ₹2,820.67 lakhs (compared to ₹3,144.49 lakhs in FY25)
  • Total Expenses: ₹2,644.23 lakhs (compared to ₹2,514.59 lakhs in FY25)
  • Profit Before Tax: ₹176.44 lakhs (compared to ₹505.43 lakhs in FY25)
  • Current Tax Expense: ₹139.13 lakhs
  • Profit for the Period (Net Profit): ₹37.31 lakhs (compared to ₹544.15 lakhs in FY25)
  • Total Comprehensive Income: ₹69.38 lakhs
  • Earnings Per Share (Basic and Diluted): ₹0.15 (compared to ₹1.15 in FY25)

Financial Position (As at March 31, 2026):

  • Total Assets: ₹10,319.73 lakhs (compared to ₹11,121.16 lakhs in FY25)
  • Share Capital: ₹473.13 lakhs (unchanged)
  • Other Equity: ₹1,298.92 lakhs (compared to ₹523.48 lakhs in FY25)
  • Total Borrowings (Non-current + Current): ₹3,462.79 lakhs
  • Trade Payables: ₹4,221.45 lakhs

Cash Flows (Year Ended March 31, 2026):

  • Net Cash From Operating Activities: ₹1,084.40 lakhs
  • Net Cash Used In Investing Activities: ₹(470.11) lakhs
  • Net Cash Used in Financing Activities: ₹(264.21) lakhs
  • Net Increase in Cash and Cash Equivalents: ₹11.21 lakhs

Dates of Action

  • Board Meeting Date: May 29, 2026 (Friday)
  • Meeting Time: Commenced at 03:55 p.m. and concluded at 4:35 p.m.
  • Financial Period: Quarter and year ended March 31, 2026
  • Audit Report Date: May 29, 2026

Parties Involved

  • Statutory Auditors: Neeraj Arora & Associates, Chartered Accountants (Registration No.: 021309)
  • Managing Director & CEO: Sameer Goel (DIN: 00161786)
  • Chief Financial Officer: Mani Jain
  • Company Secretary: Abhishek K. Pandey
  • Banks: Kotak Mahindra Bank Limited (provided working capital limits)

Operational Highlights

  • The company maintains a DSIR-approved R&D facility at Village Bhondsi, Tehsil Sohna, District Gurugram, Haryana (Registration No. TU/IV-RD/4410/2018 dated January 22, 2019)
  • The facility is engaged in development of new products and processes, improvement of existing products, and development of new Active Pharmaceutical Ingredients (APIs)
  • Working capital limits sanctioned from Kotak Mahindra Bank Limited: ₹29.60 crores (₹15.60 crores with balance of ₹8.71 crores and ₹14.00 crores fully utilized)

Capital Structure Impact

  • Redeemed preference share capital amounting to ₹8,00,00,000.00 (₹8 crores) during the first and second quarters of the financial year
  • No change in equity share capital during the year

Audit Matters

  • Auditors issued an unmodified opinion on the financial statements
  • Key audit matters identified: Revenue Recognition (Ind AS 115 implementation) and R&D Expenditure accounting
  • Internal financial controls were found to be adequate and operating effectively

Contingencies and Commitments

  • Pending litigations disclosed in Note 37 to financial statements (impact not quantified)
  • No long-term contracts including derivative contracts with material foreseeable losses
  • No amounts required to be transferred to Investor Education and Protection Fund

Other Disclosures

  • The company uses SAP Basics accounting software with audit trail feature operational throughout the year
  • No dividend paid during the year ended March 31, 2026
  • No fraud reported by auditors or whistle blower complaints received during the year